Results 1 to 10 of about 1,854,852 (401)

Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.

open access: yesImmunology and Allergy Clinics of North America, 2023
Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing interstitial pneumonia, with an unknown cause. IPF has been linked to several genetic and environmental risk factors. Disease progression is common and associated with worse outcomes.
R. Strykowski, A. Adegunsoye
semanticscholar   +3 more sources

Genome-wide DNA methylation dynamics in carbon tetrachloride-induced mice liver fibrosis [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2023
Objective(s): Many persistent harmful stimuli can result in chronic liver diseases, which lead to about 2 million deaths per year in the whole world. Liver fibrosis was found to exist in all kinds of chronic liver diseases.
Deming Li   +5 more
doaj   +1 more source

Nos2 deficiency enhances carbon tetrachloride-induced liver injury in aged mice [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2020
Objective(s): As a multifunctional molecule, NO has different effects on liver injury. The present work aimed to investigate the effects of Nos2 knockout (KO) on acute liver injury in aged mice treated with carbon tetrachloride (CCl4).
Deming Li   +7 more
doaj   +1 more source

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2022
Background This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior idiopathic pulmonary fibrosis (IPF) guidelines and addresses the progression of ...
G. Raghu   +40 more
semanticscholar   +1 more source

Global incidence and prevalence of idiopathic pulmonary fibrosis

open access: yesRespiratory Research, 2021
Background Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease with considerable morbidity. Heterogeneity in epidemiologic studies means the full impact of the disease is unclear.
T. Maher   +7 more
semanticscholar   +1 more source

Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine

open access: yesBMC Medical Education, 2022
Background The purpose of the National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is to improve and extend the lives of patients living with pulmonary fibrosis through the development of a ...
Katherine Christian   +7 more
doaj   +1 more source

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis

open access: yesFrontiers in Pharmacology, 2022
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal fibrotic lung disease that occurs primarily in middle-aged and elderly adults. It is a major cause of morbidity and mortality. With an increase in life expectancy, the economic burden of IPF is
Qian Mei   +4 more
semanticscholar   +1 more source

[Idiopathic pulmonary fibrosis].

open access: yesMedecine sciences : M/S, 2022
38;6 ...
Hennion, Nathan   +4 more
  +9 more sources

Idiopathic pulmonary fibrosis: Current and future treatment

open access: yesClinical Respiratory Journal, 2022
Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease characterized by dry cough, fatigue, and progressive exertional dyspnea. Lung parenchyma and architecture is destroyed, compliance is lost, and gas exchange is compromised in this ...
Daniel S. Glass   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy